Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia

NCT02104752 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

FED

Sponsor class

Conditions

Schizophrenia
Cognition
Psychosis

Interventions

DRUG: Curcumin
DRUG: Placebo

Sponsor

VA Greater Los Angeles Healthcare System

Collaborators

[object Object]
[object Object]
[object Object]